NON INVASIVE MONITORING SYSTEMS INC /FL/ Business Summary

Non-Invasive Monitoring Systems Inc. (NIMU) operates as a medical technology company primarily focused on the development and commercialization of its Exer-Rest line of acceleration therapeutic platforms. The company generates revenue through the direct sale of its proprietary devices, including the Exer-Rest AT3800 and AT4700, which utilize patented Whole Body Periodic Acceleration (WBPA) technology to provide passive exercise for individuals with limited mobility. While the company historically derived income from licensing and royalties on diagnostic monitoring patents assigned to entities like SensorMedics and VivoMetrics, its current business model is centered on the therapeutic wellness segment, specifically targeting symptoms of chronic cardiovascular, neurological, and musculoskeletal conditions. NIMU competes directly with manufacturers of passive motion and vibration therapy equipment such as Power Plate, LifePro, and DJO Global (a subsidiary of Enovis). Within this landscape, NIMU occupies a specialized medical-grade niche, positioning its WBPA technology as a clinically validated solution for patients for whom traditional active exercise is contraindicated. The company’s leadership is deeply integrated with the executive team of OPKO Health, reflecting a lean operational structure that relies on cost-sharing and consultancy rather than a full-time employee base. Jane H. Hsiao, Ph.D., MBA, serves as the Chairman and Interim Chief Executive Officer, bringing extensive experience from her concurrent roles as Vice Chairman and Chief Technical Officer of OPKO Health. The executive team includes Chief Financial Officer and Director James Martin, while the Board of Directors is anchored by prominent investor and OPKO Health CEO Dr. Phillip Frost, who remains a major beneficial shareholder. In September 2025, the board was further strengthened by the appointment of Adam Logal, the current CFO of OPKO Health, following the resignation of Subbarao Uppaluri. The company was founded by the late Dr. Marvin A. Sackner, a renowned pulmonologist and pioneer in non-invasive diagnostic technology, whose legacy continues to drive the firm’s focus on non-invasive therapeutic interventions.